Secreted miR-153 Controls Proliferation and Invasion of Higher Gleason Score Prostate Cancer

• Published in: International journal of molecular sciences 2022-06, Vol.23 (11), p.6339
• Main Authors: Bertoli, Gloria, Panio, Antonella, Cava, Claudia, Gallivanone, Francesca, Alini, Martina, Strano, Giulia, Molfino, Federico, Brioschi, Loredana, Viani, Paola, Porro, Danilo
• Format: Article
• Language: English
• Subjects: Biomarkers; Biopsy; Cell growth; Cell proliferation; Cell Proliferation - genetics; Diagnosis; Exosomes; Gene expression; Humans; Krueppel-like factor; Magnetic resonance imaging; Male; Metastasis; Microenvironments; MicroRNAs; MicroRNAs - genetics; Mortality; Neoplasia; Neoplasm Grading; Prostate cancer; Prostate-Specific Antigen; Prostatic Neoplasms - metabolism; Surveillance; Tumor Microenvironment
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23116339

Prostate cancer (PC) is a male common neoplasm and is the second leading cause of cancer death in American men. PC is traditionally diagnosed by the evaluation of prostate secreted antigen (PSA) in the blood. Due to the high levels of false positives, digital rectal examination and transrectal ultrasound guided biopsy are necessary in uncertain cases with elevated PSA levels. Nevertheless, the high mortality rate suggests that new PC biomarkers are urgently needed to help clinical diagnosis. In a previous study, we have identified a network of genes, altered in high Gleason Score (GS) PC (GS ≥ 7), being regulated by miR-153. Until now, no publication has explained the mechanism of action of miR-153 in PC. By in vitro studies, we found that the overexpression of miR-153 in high GS cell lines is required to control cell proliferation, migration and invasion rates, targeting Kruppel-like factor 5 ( ). Moreover, miR-153 could be secreted by exosomes and microvesicles in the microenvironment and, once entered into the surrounding tissue, could influence cellular growth. Being upregulated in high GS human PC, miR-153 could be proposed as a circulating biomarker for PC diagnosis.